{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T06:31:46Z","timestamp":1791959506956,"version":"4.3.4"},"reference-count":36,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2018,4,9]],"date-time":"2018-04-09T00:00:00Z","timestamp":1523232000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,10,15]]},"abstract":"<jats:p>In a retrospective cohort study of 170 solid organ transplant recipients who completed treatment for an episode of cytomegalovirus disease, absolute lymphocyte count within a week of cessation of primary treatment emerged as an independent predictor of relapse.<\/jats:p>","DOI":"10.1093\/cid\/ciy295","type":"journal-article","created":{"date-parts":[[2018,4,7]],"date-time":"2018-04-07T07:09:31Z","timestamp":1523084971000},"page":"1395-1402","source":"Crossref","is-referenced-by-count":100,"title":["Absolute Lymphocyte Count: A Predictor of Recurrent Cytomegalovirus Disease in Solid Organ Transplant Recipients"],"prefix":"10.1093","volume":"67","author":[{"given":"Bradley J","family":"Gardiner","sequence":"first","affiliation":[{"name":"Division of Geographic Medicine and Infectious Diseases, Tufts Medical Center and Tufts University School of Medicine, Boston, Massachusetts"},{"name":"Department of Infectious Diseases, Alfred Hospital and Monash University, Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie E","family":"Nierenberg","sequence":"additional","affiliation":[{"name":"Division of Geographic Medicine and Infectious Diseases, Tufts Medical Center and Tufts University School of Medicine, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer K","family":"Chow","sequence":"additional","affiliation":[{"name":"Division of Geographic Medicine and Infectious Diseases, Tufts Medical Center and Tufts University School of Medicine, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin","family":"Ruthazer","sequence":"additional","affiliation":[{"name":"Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, Massachusetts"},{"name":"Tufts Clinical and Translational Science Institute, Tufts University, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M","family":"Kent","sequence":"additional","affiliation":[{"name":"Tufts Clinical and Translational Science Institute, Tufts University, Boston, Massachusetts"},{"name":"Predictive Analytics and Comparative Effectiveness Center, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center and Tufts University School of Medicine, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David R","family":"Snydman","sequence":"additional","affiliation":[{"name":"Division of Geographic Medicine and Infectious Diseases, Tufts Medical Center and Tufts University School of Medicine, Boston, Massachusetts"},{"name":"Tufts Clinical and Translational Science Institute, Tufts University, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,4,9]]},"reference":[{"key":"2019120223404900000_CIT0001","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1128\/CMR.00034-08","article-title":"Immunobiology of human cytomegalovirus: from bench to bedside","volume":"22","author":"Crough","year":"2009","journal-title":"Clin Microbiol Rev"},{"key":"2019120223404900000_CIT0002","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1146\/annurev-virology-110615-042422","article-title":"Human cytomegalovirus latency: approaching the Gordian knot","volume":"3","author":"Goodrum","year":"2016","journal-title":"Annu Rev Virol"},{"key":"2019120223404900000_CIT0003","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/ajt.12103","article-title":"Cytomegalovirus in solid organ transplantation","volume":"13","author":"Razonable","year":"2013","journal-title":"Am J Transplant"},{"key":"2019120223404900000_CIT0004","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.transproceed.2011.02.069","article-title":"Update and review: state-of-the-art management of cytomegalovirus infection and disease following thoracic organ transplantation","volume":"43","author":"Snydman","year":"2011","journal-title":"Transplant Proc"},{"key":"2019120223404900000_CIT0005","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1111\/j.1600-6143.2009.02824.x","article-title":"The \u2018indirect\u2019 effects of cytomegalovirus infection","volume":"9","author":"Freeman","year":"2009","journal-title":"Am J Transplant"},{"key":"2019120223404900000_CIT0006","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/TP.0b013e31829df29d","article-title":"Updated international consensus guidelines on the management of cytomegalovirus in solid-organ transplantation","volume":"96","author":"Kotton","year":"2013","journal-title":"Transplantation"},{"key":"2019120223404900000_CIT0007","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1097\/TP.0000000000001338","article-title":"Recurrence of CMV infection and the effect of prolonged antivirals in organ transplant recipients","volume":"101","author":"Natori","year":"2017","journal-title":"Transplantation"},{"key":"2019120223404900000_CIT0008","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.1600-6143.2009.02861.x","article-title":"Clinical predictors of relapse after treatment of primary gastrointestinal cytomegalovirus disease in solid organ transplant recipients","volume":"10","author":"Eid","year":"2010","journal-title":"Am J Transplant"},{"key":"2019120223404900000_CIT0009","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1097\/00007890-199901150-00016","article-title":"Cytomegalovirus disease recurrence after ganciclovir treatment in kidney and kidney-pancreas transplant recipients","volume":"67","author":"Humar","year":"1999","journal-title":"Transplantation"},{"key":"2019120223404900000_CIT0010","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1001\/archsurg.1993.01420140042007","article-title":"Treatment of recurrent cytomegalovirus disease in patients receiving solid organ transplants","volume":"128","author":"Sawyer","year":"1993","journal-title":"Arch Surg"},{"key":"2019120223404900000_CIT0011","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1111\/j.1600-6143.2009.02617.x","article-title":"Long-term outcomes of CMV disease treatment with valganciclovir versus IV ganciclovir in solid organ transplant recipients","volume":"9","author":"Asberg","year":"2009","journal-title":"Am J Transplant"},{"key":"2019120223404900000_CIT0012","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1111\/j.1600-6143.2010.03114.x","article-title":"Effects of the intensity of immunosuppressive therapy on outcome of treatment for CMV disease in organ transplant recipients","volume":"10","author":"Asberg","year":"2010","journal-title":"Am J Transplant"},{"key":"2019120223404900000_CIT0013","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1086\/514555","article-title":"Clinical and epidemiological predictors of recurrent cytomegalovirus disease in orthotopic liver transplant recipients. Boston Center for Liver Transplantation CMVIG Study Group","volume":"25","author":"Falagas","year":"1997","journal-title":"Clin Infect Dis"},{"key":"2019120223404900000_CIT0014","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1111\/j.1432-2277.2011.01321.x","article-title":"The risk of cytomegalovirus recurrence after kidney transplantation","volume":"24","author":"Helanter\u00e4","year":"2011","journal-title":"Transpl Int"},{"key":"2019120223404900000_CIT0015","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1111\/tid.12247","article-title":"Current characteristics and outcome of cytomegalovirus infections after kidney transplantation","volume":"16","author":"Helanter\u00e4","year":"2014","journal-title":"Transpl Infect Dis"},{"key":"2019120223404900000_CIT0016","first-page":"231","article-title":"Prevalence and risk factors of recurrent cytomegalovirus infection in kidney transplant recipients","volume":"8","author":"Nafar","year":"2014","journal-title":"Iran J Kidney Dis"},{"key":"2019120223404900000_CIT0017","volume-title":"Guidelines for the prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from the Centers for Disease Control and Prevention, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America","author":"Panel on Opportunistic Infections in HIV-Infected Adults and Adolescents"},{"key":"2019120223404900000_CIT0018","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1182\/blood.V82.5.1672.bloodjournal8251672","article-title":"Lymphocytopenia as an unfavorable prognostic factor in patients with cytomegalovirus infection after bone marrow transplantation","volume":"82","author":"Einsele","year":"1993","journal-title":"Blood"},{"key":"2019120223404900000_CIT0019","first-page":"1387","article-title":"Declining lymphocyte counts following cytomegalovirus (CMV) infection are associated with fatal CMV disease in bone marrow transplant patients","volume":"21","author":"Fries","year":"1993","journal-title":"Exp Hematol"},{"key":"2019120223404900000_CIT0020","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1016\/j.transproceed.2009.05.008","article-title":"Incidence and predictive factors for cytomegalovirus infection in renal transplant recipients","volume":"41","author":"Corona-Nakamura","year":"2009","journal-title":"Transplant Proc"},{"key":"2019120223404900000_CIT0021","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1002\/lt.21833","article-title":"Pretransplant lymphocyte count predicts the incidence of infection during the first two years after liver transplantation","volume":"15","author":"Fern\u00e1ndez-Ruiz","year":"2009","journal-title":"Liver Transpl"},{"key":"2019120223404900000_CIT0022","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1002\/lt.23991","article-title":"Pretransplant lymphopenia is a novel prognostic factor in cytomegalovirus and noncytomegalovirus invasive infections after liver transplantation","volume":"20","author":"Nierenberg","year":"2014","journal-title":"Liver Transpl"},{"key":"2019120223404900000_CIT0023","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1097\/TP.0b013e318239e90c","article-title":"Kinetics of T-lymphocyte subsets and posttransplant opportunistic infections in heart and kidney transplant recipients","volume":"93","author":"Calarota","year":"2012","journal-title":"Transplantation"},{"key":"2019120223404900000_CIT0024","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1111\/tri.12321","article-title":"Kinetics of peripheral blood lymphocyte subpopulations predicts the occurrence of opportunistic infection after kidney transplantation","volume":"27","author":"Fern\u00e1ndez-Ruiz","year":"2014","journal-title":"Transpl Int"},{"key":"2019120223404900000_CIT0025","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1093\/infdis\/166.6.1228","article-title":"Recovery from cytomegalovirus infection is associated with activation of peripheral blood lymphocytes","volume":"166","author":"van den Berg","year":"1992","journal-title":"J Infect Dis"},{"key":"2019120223404900000_CIT0026","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1093\/cid\/cix696","article-title":"Role of secondary prophylaxis with valganciclovir in the prevention of recurrent cytomegalovirus disease in solid organ transplant recipients","volume":"65","author":"Gardiner","year":"2017","journal-title":"Clin Infect Dis"},{"key":"2019120223404900000_CIT0027","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1093\/cid\/ciw668","article-title":"Definitions of cytomegalovirus infection and disease in transplant patients for use in clinical trials","volume":"64","author":"Ljungman","year":"2017","journal-title":"Clin Infect Dis"},{"key":"2019120223404900000_CIT0028","first-page":"34","article-title":"Recurrent cytomegalovirus disease in solid-organ transplant recipients","volume":"27","author":"Falagas","year":"1995","journal-title":"Transplant Proc"},{"key":"2019120223404900000_CIT0029","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.3390\/v6062242","article-title":"Controlling cytomegalovirus: helping the immune system take the lead","volume":"6","author":"Hanley","year":"2014","journal-title":"Viruses"},{"key":"2019120223404900000_CIT0030","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/j.1399-3062.2009.00443.x","article-title":"Relapsing cytomegalovirus infection in solid organ transplant recipients","volume":"11","author":"Shanahan","year":"2009","journal-title":"Transpl Infect Dis"},{"key":"2019120223404900000_CIT0031","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1086\/342601","article-title":"Cytomegalovirus (CMV) virus load kinetics to predict recurrent disease in solid-organ transplant patients with CMV disease","volume":"186","author":"Humar","year":"2002","journal-title":"J Infect Dis"},{"key":"2019120223404900000_CIT0032","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1198\/000313007X172556","article-title":"Much ado about nothing: a comparison of missing data methods and software to fit incomplete data regression models","volume":"61","author":"Horton","year":"2007","journal-title":"Am Stat"},{"key":"2019120223404900000_CIT0033","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1093\/cid\/cis993","article-title":"Assessment of cytomegalovirus-specific cell-mediated immunity for the prediction of cytomegalovirus disease in high-risk solid-organ transplant recipients: a multicenter cohort study","volume":"56","author":"Manuel","year":"2013","journal-title":"Clin Infect Dis"},{"key":"2019120223404900000_CIT0034","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1586\/erm.10.109","article-title":"QuantiFERON\u00ae-CMV assay for the assessment of cytomegalovirus cell-mediated immunity","volume":"11","author":"Giulieri","year":"2011","journal-title":"Expert Rev Mol Diagn"},{"key":"2019120223404900000_CIT0035","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1111\/j.1600-6143.2009.02618.x","article-title":"Cell-mediated immunity to predict cytomegalovirus disease in high-risk solid organ transplant recipients","volume":"9","author":"Kumar","year":"2009","journal-title":"Am J Transplant"},{"key":"2019120223404900000_CIT0036","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.1111\/ajt.14347","article-title":"An interventional study using cell-mediated immunity to personalize therapy for cytomegalovirus infection after transplantation","volume":"17","author":"Kumar","year":"2017","journal-title":"Am J Transplant"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/67\/9\/1395\/31191062\/ciy295.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/67\/9\/1395\/31191062\/ciy295.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T10:09:04Z","timestamp":1751537344000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/67\/9\/1395\/4964806"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,9]]},"references-count":36,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2018,4,9]]},"published-print":{"date-parts":[[2018,10,15]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciy295","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,11,1]]},"published":{"date-parts":[[2018,4,9]]}}}